Skip to Content

尊敬的客户：

目前国际形势复杂多变，关税政策尚不明朗，这可能对我们的产品价格产生一定影响。在此情况下，我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性，如果您选择在此期间下单，我们将保留根据实际情况调整价格的权利。同时，我们也理解市场变化可能给您带来的困扰，因此如果在订单实际发货前因关税政策变动导致价格出现较大波动，默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
All Photos(1)

Key Documents

View All Documentation

Safety Information

T6634

Sigma-Aldrich

Thrombin from bovine plasma

lyophilized powder, 600-2,000 NIH units/mg protein (biuret)

Synonym(s):

Factor IIa

Sign Into View Organizational & Contract Pricing

Select a Size

100 UNITS
¥1,136.34
250 UNITS
¥2,236.84
500 UNITS
¥2,438.10
1000 UNITS
¥6,612.26

¥1,136.34

Available to ship on2025年4月24日Details

Request a Bulk Order
All Photos(1)

Select a Size

Change View
100 UNITS
¥1,136.34
250 UNITS
¥2,236.84
500 UNITS
¥2,438.10
1000 UNITS
¥6,612.26

About This Item

CAS Number:
9002-04-4
Enzyme Commission number:
3.4.21.5 (BRENDA, IUBMB)
EC Number:
232-648-7
MDL number:
MFCD00166053
UNSPSC Code:
12352204
NACRES:
NA.54

¥1,136.34

Available to ship on2025年4月24日Details

Request a Bulk Order

form

lyophilized powder

Quality Level

300

specific activity

600-2,000 NIH units/mg protein (biuret)

mol wt

heavy chain ~33 kDa
light chain ~5 kDa

UniProt accession no.

P00735

application(s)

diagnostic assay manufacturing

storage temp.

−20°C

Gene Information

cow ... F2(280685)

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
T7009T7513T4648
凝血酶 来源于牛血浆 lyophilized powder, 600-2,000 NIH units/mg protein (biuret)

T6634

凝血酶 来源于牛血浆

Thrombin 来源于人类血浆 lyophilized powder, ≥1,000 NIH units/mg protein (E1%/280, 18.3)

T7009

Thrombin 来源于人类血浆

凝血酶 来源于牛血浆 lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280 = 19.5)

T7513

凝血酶 来源于牛血浆

凝血酶 来源于牛血浆 lyophilized powder, 40-500 NIH units/mg protein (biuret)

T4648

凝血酶 来源于牛血浆

Gene Information

cow ... F2(280685)

Gene Information

human ... F2(2147)

Gene Information

cow ... F2(280685)

Gene Information

cow ... F2(280685)

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

application(s)

diagnostic assay manufacturing

application(s)

diagnostic assay manufacturing

application(s)

diagnostic assay manufacturing

application(s)

-

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

UniProt accession no.

P00735

UniProt accession no.

P00734

UniProt accession no.

P00735

UniProt accession no.

P00735

General description

Thrombin is a sodium-activated type II enzyme. It contains two anion binding exosites, ABE-I and ABE-II.[1] The predominant form of thrombin in vivo is the zymogen prothrombin (factor II), which is produced in the liver.[2] Bovine a-thrombin consists of a light chain (A chain) and a heavy chain (B chain). These two chains are joined by one disulfide bond.[3] The B chain of a-thrombin includes a carbohydrate portion.[4]

Application

Thrombin from bovine plasma has been used to study its effect on the perinatal rat subventricular zone cells and oligodendrocyte precursor cell proliferation, differentiation, and migration in culture.[5] It has also been used in fibrin degradation assay to measure nattokinase activity.[6]
Thrombin is used for site specific cleavage of recombinant fusion proteins containing an accessible thrombin recognition site for removal of affinity tags. Thrombin has been used in a study to assess global haemostasis and point of care testing. [7]

Biochem/physiol Actions

Serine protease that selectively cleaves Arg-Gly bonds in fibrinogen to form fibrin and fibrinopeptides A and B.
Thrombin is a proteolytic enzyme critical in the blood clotting process and activates clotting factors V, VIII, XI, and XII. Thrombin promotes platelet aggregation. Therefore, thrombin is the final coagulation protease in hemostasis, promoting both procoagulant and anticoagulant effects.[4] It is used to treat bleeding from capillaries and small venules.[3]

Unit Definition

Activity is expressed in NIH units obtained by direct comparison to a NIH thrombin reference standard.

Physical form

Lyophilized from saline sodium citrate buffer, pH 6.5

Analysis Note

Activity is expressed in NIH units obtained by direct comparison to a NIH Thrombin Reference Standard, Lot K.
The NIH assay procedure uses 0.2 mL of diluted plasma (1:1 with saline) as a substrate and 0.1 mL of thrombin sample (stabilized in a 1% buffered albumin solution) based on a modification of the method of Biggs. Only clotting times in the range of 15-25 seconds are used for determining thrombin concentrations.

Other Notes

View more information on thrombin at www.sigma-aldrich.com/enzymeexplorer.

inhibitor

Product No.
Description
Pricing

substrate

Product No.
Description
Pricing

Pictograms

Health hazardExclamation mark
GHS08,GHS07

Signal Word

Danger

Hazard Statements

H315,H319,H334,H335

Hazard Classifications

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

动植物源性产品
  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    0000422686
    0000422686
    0000409285
    0000409286
    0000406769

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Akiomi Takano et al.
    Investigative ophthalmology & visual science, 47(5), 2075-2079 (2006-04-28)
    To investigate the effects of intravitreal injection of nattokinase (subtilisin NAT), a serine protease that is produced by Bacillus subtilis (natto), for induction of posterior vitreous detachment (PVD). Different doses of nattokinase (1, 0.1, or 0.01 fibrin-degradation units [FU]) or
    Hongkai Xiang et al.
    The Journal of international medical research, 48(9), 300060520957541-300060520957541 (2020-09-26)
    To assess changes in plasma exosome levels and protein content in mice after long-term exercise. We subjected 9-month-old adult C57BL/6J mice to daily treadmill running exercise for 4 weeks prior to the isolation of blood-derived exosomes. Exosomal proteins were identified
    Fergal J Duffy et al.
    Journal of chemical information and modeling, 55(3), 600-613 (2015-02-11)
    Protein-protein and protein-peptide interactions are responsible for the vast majority of biological functions in vivo, but targeting these interactions with small molecules has historically been difficult. What is required are efficient combined computational and experimental screening methods to choose among
    Thrombin as an Agent
    xPharm: The Comprehensive Pharmacology Reference null
    Thrombin as a Target
    xPharm: The Comprehensive Pharmacology Reference null
    View All Related Papers

    Articles

    Thrombin Factor IIa

    Thrombin Factor IIa is an endolytic serine protease that selectively cleaves the Arg--Gly bonds of fibrinogen to form fibrin and release fibrinopeptides A and B.

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service